Submission to the Patented Medicines Pricing Review Board Re: Scoping paper for the consultations of the Board's Guidelines
Release Date: 12/20/2023 Staff Reference: Joan WeirThe Canadian Life and Health Insurance Association is pleased to provide the views of its members to the Patented Medicines Pricing Review Board for consideration regarding the Scoping Paper.
These views help to inform the upcoming industry consultation for the development of new guidelines.
